Product Image

Boswellia Resin Extract

Solgar
4.6
★ ★ ★ ★ ★
(2182 ratings)
Boswellia 350 mg
Product Image
Score78
Meaningful extract and powder amounts offer good practical value, though active-marker disclosure and absorption support remain limited.
How scoring works
Quantity:60 Capsule(s) • (60 servings)
Goals:
Anti-Inflammatory Support
Joint Health

Score 78

Meaningful extract and powder amounts offer good practical value, though active-marker disclosure and absorption support remain limited.
How scoring works
$14.51($0.24 per serving)
Pure Formulas
$ 15.37
iHerb
$ 14.51
Vitacost
$ 15.55
Amazon
$ 15.37
Daily Vita
$ 15.37
Report prices

Analysis

The serving combines 350 mg of standardized Boswellia extract with 70 mg of resin powder. That pairing supplies a meaningful total amount and keeps the formula tightly focused on Boswellia.

Calling the extract standardized is helpful, but the label does not say what percentage is boswellic acids or how much AKBA is present. The missing marker values prevent a clear comparison with more precisely characterized extracts.

A one-capsule serving and favorable ongoing cost support practical daily use. The dry capsule lacks a lipid carrier or absorption enhancer, making it a value-oriented choice rather than the most technically refined option.

Who is it for
  • Adults wanting focused Boswellia support
  • People seeking a one-capsule serving
  • Value-focused buyers who accept partial standardization details
Best for
  • Daily joint-comfort support
  • Simple single-botanical use
  • Affordable standardized-extract supplementation

Pros

  • Combines standardized extract with resin powder
  • Useful total Boswellia amount
  • Convenient daily capsule

Cons

  • Boswellic-acid percentage is not stated
  • AKBA amount is not disclosed
  • No stated absorption support

Warnings

  • Boswellia can cause digestive upset, including nausea or loose stools.
  • Boswellia may increase bleeding tendency with anticoagulant or antiplatelet medicines.
  • Discontinue use if the resin ingredients trigger rash, swelling, or other allergy symptoms.

Nutrient quality

82 Highest impact

The substantial extract and powder amount directly fits Boswellia use. Missing active-acid percentages and absorption support limit potency assurance.

.

Ingredient transparency

76 High impact

Both Boswellia amounts are disclosed without a hidden blend. Intake directions, inactive ingredients, and active-marker percentages are absent.

.

Customer satisfaction

68 High impact

The supplied average rating is strong and comes from a substantial rating pool. No firsthand experiences or recurring complaint details were provided, so consistency remains uncertain.

.

Value for money

83 Highest impact

A substantial focused serving provides good value at a modest cost. Incomplete standardization is the main limit on competitiveness.

.
Report analysis

Goals

Anti-Inflammatory Support
Anti-Inflammatory Support
Impact
High effect
A- Goal FitB Strength of SupportC- CoverageA- Formula Quality
Boswellia · 70 mg

Boswellia is directly relevant because its boswellic acids can modulate the 5-LOX inflammatory pathway. The combined extract and resin powder provide a substantial, focused serving for joint-related comfort.

The label does not state the total boswellic acid or AKBA percentage, so potency cannot be compared with better-standardized extracts. A plain dry capsule also offers no stated absorption support, and the single-botanical design covers only one main pathway.

Study evidence
Boswellia Supportive 19 studies
Joint Health
Joint Health
Impact
High effect
B+ Goal FitB- Strength of SupportC- CoverageA Formula Quality
Boswellia · 70 mg

Boswellia extract directly targets a pathway linked to joint comfort, and the serving amount is in a commonly used range. Human evidence supports standardized extracts, although the label does not quantify boswellic acids or AKBA.

The dry capsule provides no absorption enhancer, which lowers confidence in active delivery. The focused formula remains more relevant than a broad blend of underdosed ingredients.

Study evidence
Boswellia Supportive 24 studies

Ingredients

IngredientAmount per serving
standardized Boswellia extract (Boswelic Acid)
 350 mg
Boswellia powder
70 mg
Gluten Free Adults 18–50 Vegan Kosher Dairy Free Sugar Free Vegetarian
Report overview
Boswellia (Boswelic Acid) · 350 mg OverallScore62
F Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyB- Value

The extract amount is clear, but the label does not quantify total boswellic acids or AKBA. The dry capsule adds no absorption enhancer, while the dose fits the usual standard-extract range. The cost is favorable, although incomplete standardization limits quality confidence.

View ingredientView products
Loading alternative details
84 Performance

Boswellia Extract 500 mg

California Gold Nutrition
<p>A 500 mg branded Boswellin extract plus 200 mg of turmeric extract broadens joint-focused ingredient coverage beyond the original extract-plus-powder formula. Boswellic-acid and curcuminoid percentages remain partly unclear.</p>
83 Performance

ArthroMax Advanced NT2 Collagen & ApresFlex

Life Extension
<p>Glucosamine sulfate, 100 mg of ApresFlex Boswellia, 40 mg of standardized cartilage, and boron create a more complete joint formula beyond the original extract-plus-powder formula. The recurring cost is higher, and the boron amount is modest.</p>
80 Performance

No. 7

Solgar
<p>A 100 mg 5-Loxin extract, 40 mg of UC-II, turmeric, and ginger provide several complementary joint-support ingredients beyond the original extract-plus-powder formula. Willow bark may be unsuitable for aspirin-sensitive people or those using anticoagulant or antiplatelet medicines.</p>
81 Budget

Boswellia Extract 600 mg

Herbal Secrets
<p>A focused 600 mg Boswellia gum-resin extract supplies a substantial single-ingredient amount at a lower serving cost than the original extract-plus-powder formula. The boswellic-acid percentage and an enhanced delivery method are not supplied.</p>
81 Budget

Boswellia Extract 500 mg

NOW
<p>A 500 mg Boswellia extract in a lipid-containing softgel provides a substantial, focused amount at a lower serving cost than the original extract-plus-powder formula. The active-acid percentages are unclear despite the useful amount and softgel format.</p>
81 Budget

Boswellia Serrata

Swanson
<p>Whole Boswellia plus a named 200 mg Boswellin extract provides broader plant material at a lower serving cost than the original extract-plus-powder formula. The supplied facts do not state the active-acid percentages.</p>
79 Value

Osteo Bi-Flex Triple Strength

Osteo Bi-Flex
<p>Glucosamine, 100 mg of 5-Loxin, and a chondroitin/MSM complex provide broader joint coverage with a practical balance of ingredient coverage and recurring value relative to the original extract-plus-powder formula. The combined chondroitin/MSM amount does not disclose how much of each ingredient is present.</p>
79 Value

Boswellia Extract

SuperiorLabs
<p>A 500 mg frankincense extract with 7.5 mg of black pepper provides a focused formula with an absorption-oriented addition while lowering the serving cost relative to the original extract-plus-powder formula. The boswellic-acid and AKBA percentages are not supplied, and the leucine adds little independent value.</p>
79 Value

Boswellia Serrata Extract 125 mg

Swanson Ultra
<p>A single 125 mg 5-Loxin extract provides a more specialized high-AKBA option with a practical balance of ingredient coverage and recurring value relative to the original extract-plus-powder formula. The active percentage and a separate absorption aid are not supplied.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsAnti-Inflammatory Support forBoswellia
  2. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsAnti-Inflammatory Support forBoswellia
  3. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsAnti-Inflammatory Support forBoswellia
  4. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsAnti-Inflammatory Support Joint Health forBoswellia
  5. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsAnti-Inflammatory Support Joint Health forBoswellia
  6. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  7. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia
  8. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health forBoswellia